Epithelial Barrier During Corneal Infection

角膜感染期间的上皮屏障

基本信息

  • 批准号:
    6792197
  • 负责人:
  • 金额:
    $ 30.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-09-30 至 2007-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of this application is to understand the mechanisms underlying the induction of the inflammatory reaction and breakdown of the epithelial barrier in the cornea upon infection. Recent data has shown that challenging human corneal epithelial (HCE) cells with lipopolysaccharide (LPS) isolated from Pseudomonas aeruginosa (PA), a major cause of bacterial keratitis, increases monolayer permeability and alteration of tight junction (TJ) status. LPS and PA challenges also lead to activation of NF-kappaB, a transcription factor activated by Toll-like receptor 4 (TLR4, the predominant LPS receptor in mammals). Furthermore, PA infection resulted in the loss of epithelial barrier function in cultured pig corneas. The current application will test the hypothesis that in the cornea TLRs confer responsiveness of HCE cells to pathogens, and PA challenge-induced TLR signaling, through activation of NF-kappaB and/or mitogen-activated protein kinase (MAPK), contributes to infection-induced epithelial barrier breakdown. The following studies will be carried out. (1) Alterations of barrier properties in corneal epithelial cells upon PA infection will be assessed using HCE cells cultured on Transwell filters as a model epitheliuin. Parameters to be measured include transepithelial electrical resistance, and paracellular flux, alterations in TJ proteins ZO-1 and ZO-2. (2) Signal transduction pathway(s) that couples PA challenge to alteration of epithelial barrier function in HCE cells will be characterized using antibodies to detect cell surface expression of TLRs and co-receptor CD 14, and pharmacological reagents to inhibit activation of NF-kappaB and MAPK upon HCE cell infection. (3) Whether infection-induced epithelial responses, including barrier breakdown, can be inhibited by modification of TLR-mediated signaling will be assessed. A combination of transfection of TLRs and their mutants and the neutralizing antibodies will be used to assess epithelial response to PA challenge in Transwell model epithelium. TLR neutralizing antibodies, along with other biological and pharmacological reagents, will also be applied to corneal organ culture to determine if infection-induced epithelial responses and barrier breakdown can be inhibited. An understanding of how TLRs transmit signals that lead to epithelial responses, including modulation of barrier function, may allow the development of therapeutic agents that prevent breakdown or enhance recovery of barrier function during infection and, as an adjuvant therapy, eliminate the corneal scarring and vision loss associated with bacterial keratitis.
描述(由申请人提供):本申请的长期目标是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Fu-Shin X Yu其他文献

Fu-Shin X Yu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Fu-Shin X Yu', 18)}}的其他基金

Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
  • 批准号:
    8248480
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
  • 批准号:
    7923002
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
  • 批准号:
    7844845
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
  • 批准号:
    8655872
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
  • 批准号:
    7615662
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
  • 批准号:
    8332413
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
  • 批准号:
    8840592
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
  • 批准号:
    7461874
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
  • 批准号:
    8445213
  • 财政年份:
    2008
  • 资助金额:
    $ 30.2万
  • 项目类别:
Epithelial Barrier During Corneal Infection
角膜感染期间的上皮屏障
  • 批准号:
    6525371
  • 财政年份:
    2001
  • 资助金额:
    $ 30.2万
  • 项目类别:

相似国自然基金

生物质炭负载噬菌体对土壤中抗生素耐药菌(Pseudomonas aeruginosa)迁移阻控及靶向裂解的协同机制
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    57 万元
  • 项目类别:
    面上项目
融合自组装双亲短肽提高Pseudomonas aeruginosa脂肪氧合酶热稳定性机制的研究
  • 批准号:
    31401638
  • 批准年份:
    2014
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
铜绿假单胞菌(Pseudomonas aeruginosa)SU8抑菌活性物质吩嗪-1-甲酰胺结构改造及增效作用研究
  • 批准号:
    31301709
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
铜绿假单胞菌(Pseudomonas aeruginosa)作用下PBS及其共聚物的降解途径研究
  • 批准号:
    21144008
  • 批准年份:
    2011
  • 资助金额:
    10.0 万元
  • 项目类别:
    专项基金项目
Pseudomonas aeruginosa长链烷烃羟化酶基因的研究
  • 批准号:
    30870081
  • 批准年份:
    2008
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

CAREER: A Multi-phase Biosensing Approach towards Point-of-Care Evaluation of Pseudomonas aeruginosa Virulence in Infected Chronic Wounds
职业生涯:用于护理点评估慢性感染伤口中铜绿假单胞菌毒力的多阶段生物传感方法
  • 批准号:
    2340867
  • 财政年份:
    2024
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Continuing Grant
Use of Opsonophagocytic Assay for Serological Evaluation of SimCell vaccines against Pseudomonas aeruginosa infection
使用调理吞噬试验对针对铜绿假单胞菌感染的 SimCell 疫苗进行血清学评估
  • 批准号:
    10108204
  • 财政年份:
    2024
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Collaborative R&D
Rapid detection of Pseudomonas aeruginosa in people with cystic fibrosis
快速检测囊性纤维化患者中的铜绿假单胞菌
  • 批准号:
    10103495
  • 财政年份:
    2024
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Collaborative R&D
Regulation of the virulence factor PlcH in Pseudomonas aeruginosa
铜绿假单胞菌毒力因子PlcH的调控
  • 批准号:
    10884588
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Exploiting Pf phage superinfection to lower Pseudomonas aeruginosa virulence via evolutionary tradeoffs
利用 Pf 噬菌体重复感染通过进化权衡降低铜绿假单胞菌毒力
  • 批准号:
    10748681
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Molecular Mechanisms of Pseudomonas aeruginosa Antibiotic Persistence in Monocultures and Microbial Communities
单一栽培和微生物群落中铜绿假单胞菌抗生素持久性的分子机制
  • 批准号:
    10749974
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
The role of master regulator NtrC in amyloid fibril dependent pathogenic traits of Pseudomonas aeruginosa
主调节因子 NtrC 在铜绿假单胞菌淀粉样原纤维依赖性致病性状中的作用
  • 批准号:
    10990786
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterisation of autolytic programmed cell death in Pseudomonas aeruginosa biofilms
铜绿假单胞菌生物膜中自溶程序性细胞死亡的表征
  • 批准号:
    BB/X008436/1
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Research Grant
Study of clinically over-expressed and chimeric RND multidrug efflux pumps from Acinetobacter baumannii and Pseudomonas aeruginosa
鲍曼不动杆菌和铜绿假单胞菌临床过表达和嵌合 RND 多药外排泵的研究
  • 批准号:
    23K14346
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
  • 批准号:
    10674274
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了